News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,911 Results
Type
Article (87574)
Company Profile (827)
Press Release (775490)
Multimedia
Podcasts (180)
Webinars (28)
Section
Business (233116)
Career Advice (4140)
Deals (39817)
Drug Delivery (141)
Drug Development (91298)
Employer Resources (203)
FDA (18304)
Job Trends (17407)
News (397529)
Policy (39933)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (149)
Alzheimer's disease (1696)
Antibody-drug conjugate (ADC) (273)
Approvals (18347)
Artificial intelligence (527)
Autoimmune disease (111)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (169)
Biotechnology (487)
Bladder cancer (141)
Brain cancer (54)
Breast cancer (535)
Cancer (4263)
Cardiovascular disease (381)
Career advice (3562)
Career pathing (38)
CAR-T (260)
CDC (57)
Cell therapy (720)
Cervical cancer (33)
Clinical research (75996)
Collaboration (1470)
Company closure (4)
Compensation (986)
Complete response letters (64)
COVID-19 (2966)
CRISPR (88)
C-suite (642)
Cystic fibrosis (143)
Data (5170)
Decentralized trials (2)
Denatured (65)
Depression (118)
Diabetes (472)
Diagnostics (7121)
Digital health (39)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (251)
Drug pricing (197)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99564)
Editorial (56)
Employer branding (25)
Employer resources (172)
Events (133776)
Executive appointments (1002)
FDA (20927)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (19)
Funding (1319)
Gene editing (186)
Generative AI (52)
Gene therapy (578)
GLP-1 (1050)
Government (5399)
Grass and pollen (8)
Guidances (375)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (75)
Immunology and inflammation (267)
Immuno-oncology (22)
Indications (61)
Infectious disease (3221)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17934)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (644)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (13)
Lung cancer (604)
Lymphoma (292)
Machine learning (33)
Management (66)
Manufacturing (679)
MASH (156)
Medical device (14922)
Medtech (14952)
Mergers & acquisitions (22807)
Metabolic disorders (1227)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (241)
Neuropsychiatric disorders (65)
Neuroscience (2791)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (589)
Opinion (317)
Ovarian cancer (148)
Pain (173)
Pancreatic cancer (183)
Parkinson's disease (248)
Partnered (32)
Patents (436)
Patient recruitment (347)
Peanut (58)
People (66404)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23440)
Phase II (32979)
Phase III (24867)
Pipeline (3117)
Policy (308)
Postmarket research (3554)
Preclinical (10598)
Press Release (72)
Prostate cancer (208)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (720)
Real estate (7424)
Recruiting (79)
Regulatory (28188)
Reports (65)
Research institute (2700)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (78)
Schizophrenia (140)
Series A (217)
Series B (163)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4321)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (113)
Vaccines (1071)
Venture capital (69)
Weight loss (414)
Women's health (65)
Worklife (21)
Date
Today (106)
Last 7 days (1034)
Last 30 days (3741)
Last 365 days (33666)
2025 (29447)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1285)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51114)
Australia (8986)
California (10181)
Canada (2980)
China (969)
Colorado (426)
Connecticut (453)
Delaware (291)
Europe (117526)
Florida (1485)
Georgia (331)
Hawaii (3)
Idaho (68)
Illinois (837)
India (57)
Indiana (495)
Iowa (20)
Japan (341)
Kansas (128)
Kentucky (39)
Louisiana (27)
Maine (80)
Maryland (1344)
Massachusetts (7589)
Michigan (324)
Minnesota (597)
Mississippi (4)
Missouri (128)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (81)
New Jersey (2803)
New Mexico (32)
New York (2711)
North Carolina (1467)
North Dakota (10)
Northern California (4727)
Ohio (314)
Oklahoma (22)
Oregon (51)
Pennsylvania (2088)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3885)
Tennessee (156)
Texas (1580)
United States (37184)
Utah (305)
Virginia (259)
Washington D.C. (85)
Washington State (858)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
There are 863,911 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Novartis, Vertex, More Optimizing Shots on Multiple Goals in Lucrative I&I Space
With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the third quarter, the pipeline-in-a-product strategy has never been more attractive.
November 12, 2025
·
6 min read
·
Heather McKenzie
Podcast
Pfizer Wins Metsera, Trump Strikes GLP-1 Pricing Deal, FDA Awards More Priority Vouchers
Pfizer seals the deal with Metsera for $10 billion after Novo Nordisk bowed out; President Donald Trump welcomes executives from Novo and Eli Lilly to the White House to announce that the companies’ GLP-1 medicines would be sold at a reduced cost; and the FDA grants the second round of priority review vouchers—primarily to already marketed drugs.
November 12, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Indivi Secures CHF15 Million Investment to Accelerate the Discovery of Treatment Response Biomarkers in Neuroscience Drug Development, Targeting Alzheimer’s Disease
November 12, 2025
·
2 min read
Press Releases
EirGenix Signed The Commercial Licensinse Agreement for It’s Second HER2 Biosimilar Asset EG1206A
November 12, 2025
·
3 min read
Press Releases
Cantargia Presents Nomination Committee Ahead of 2026 AGM
November 12, 2025
·
2 min read
Press Releases
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
November 12, 2025
·
5 min read
Press Releases
Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares
November 12, 2025
·
3 min read
Press Releases
Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031
November 12, 2025
·
9 min read
Press Releases
DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
November 12, 2025
·
4 min read
Press Releases
Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences - November 11, 2025
November 12, 2025
·
2 min read
1 of 86,392
Next
